# Influence of Olfaction Essential Oils on the Consumption of Benzodiazepine Receptor Agonists & Z-Drugs (BZRAs) Prescribed as " if Needed " in Psychiatric Outpatients (HECBA-PSY).

> **NCT05583240** · PHASE4 · UNKNOWN · sponsor: **Etablissement Public de Santé Barthélemy Durand** · enrollment: 50 (estimated)

## Conditions studied

- Psychiatric Disorder
- Benzodiazepine Withdrawal

## Interventions

- **DRUG:** Essences and Essential Oils

## Key facts

- **NCT ID:** NCT05583240
- **Lead sponsor:** Etablissement Public de Santé Barthélemy Durand
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-19
- **Primary completion:** 2023-04-18
- **Final completion:** 2023-07-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05583240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05583240, "Influence of Olfaction Essential Oils on the Consumption of Benzodiazepine Receptor Agonists & Z-Drugs (BZRAs) Prescribed as " if Needed " in Psychiatric Outpatients (HECBA-PSY).". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05583240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*